{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:07:47Z","timestamp":1793754467416,"version":"4.6.1"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014261","name":"NIHCM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL108793-06"],"award-info":[{"award-number":["P01HL108793-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaut.2023.103107","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T15:33:03Z","timestamp":1697729583000},"page":"103107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Pulmonary sarcoidosis: A comprehensive review: Past to present"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2379-5486","authenticated-orcid":false,"given":"John A.","family":"Belperio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Abtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Channick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh A.","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Lynch III","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.2022.7774","article-title":"A review of the diagnosis and treatment of pulmonary sarcoidosis-reply","volume":"328","author":"Belperio","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jaut.2023.103107_bib2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2022.1570","article-title":"Diagnosis and treatment of pulmonary sarcoidosis: a review","volume":"327","author":"Belperio","year":"2022","journal-title":"JAMA"},{"issue":"29","key":"10.1016\/j.jaut.2023.103107_bib3","article-title":"Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain","volume":"96","author":"Mana","year":"2017","journal-title":"Medicine (Baltim.)"},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","article-title":"Course and prognosis of sarcoidosis around the world","volume":"57","author":"Siltzbach","year":"1974","journal-title":"Am. J. Med."},{"issue":"9923","key":"10.1016\/j.jaut.2023.103107_bib5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"issue":"10 Pt 1","key":"10.1016\/j.jaut.2023.103107_bib6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-2007-970333","article-title":"Pulmonary sarcoidosis","volume":"28","author":"Lynch","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"7\u20138","key":"10.1016\/j.jaut.2023.103107_bib8","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol. Jpn."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","article-title":"Epidemiology of sarcoidosis 1946-2013: a population-based study","volume":"91","author":"Ungprasert","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jaut.2023.103107_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rmed.2018.11.010","article-title":"Sarcoidosis deaths in the United States: 1999-2016","volume":"149","author":"Kearney","year":"2019","journal-title":"Respir. Med."},{"issue":"11","key":"10.1016\/j.jaut.2023.103107_bib11","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.jaut.2023.103107_bib12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/thx.2006.062836","article-title":"Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK","volume":"61","author":"Gribbin","year":"2006","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01815-2017","article-title":"Sarcoidosis mortality in Sweden: a population-based cohort study","volume":"51","author":"Rossides","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103107_bib202","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(63)90165-7","article-title":"Manifestations of sarcoidosis: analysis of 145 patients, with a review of nine series selected from the literature","volume":"35","author":"Mayock","year":"1963","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib94","first-page":"544","article-title":"A comparison of the value of mediastinal lymph node biopsy and the Kveim test in sarcoidosis","volume":"104","author":"Mikhail","year":"1971","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jaut.2023.103107_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106548","article-title":"Sarcoidosis: a nationwide registry-based study of incidence, prevalence and diagnostic work-up","volume":"187","author":"Sikjaer","year":"2021","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ACI.0b013e3283515173","article-title":"Occupational causes of sarcoidosis","volume":"12","author":"Newman","year":"2012","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2023.103107_bib73","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.4049\/jimmunol.176.12.7354","article-title":"BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation","volume":"176","author":"Nguyen","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12931-018-0871-3","article-title":"Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study","volume":"19","author":"Yoon","year":"2018","journal-title":"Respir. Res."},{"issue":"8","key":"10.1016\/j.jaut.2023.103107_bib14","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. Analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1183\/09031936.00197808","article-title":"Prevalence of sarcoidosis in Switzerland is associated with environmental factors","volume":"35","author":"Deubelbeiss","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1513\/AnnalsATS.201508-568BC","article-title":"Epidemiology of sarcoidosis in a prospective cohort study of U.S. Women","volume":"13","author":"Dumas","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.jaut.2023.103107_bib203","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1749-6632.1976.tb47043.x","article-title":"A worldwide review of sarcoidosis","volume":"278","author":"James","year":"1976","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib92","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jtcvs.2012.01.040","article-title":"Prospective study of endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue for diagnosis of sarcoidosis","volume":"143","author":"Oki","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.rmed.2012.02.007","article-title":"Unexpectedly high prevalence of sarcoidosis in a representative U.S. Metropolitan population","volume":"106","author":"Erdal","year":"2012","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib26","first-page":"29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jaut.2023.103107_bib100","first-page":"525","article-title":"Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients","volume":"208","author":"Neville","year":"1983","journal-title":"Q. J. Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1378\/chest.10-0413","article-title":"Sarcoidosis in black women in the United States: data from the black women's health study","volume":"139","author":"Cozier","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib98","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1183\/09031936.00075307","article-title":"Epidemiology of sarcoidosis in Japan","volume":"31","author":"Morimoto","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.202204-328OC","article-title":"Heterogeneity of lung function phenotypes in sarcoidosis: role of race and sex differences","volume":"20","author":"Sharp","year":"2023","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.jaut.2023.103107_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2019.08.025","article-title":"Systemic phenotype of sarcoidosis associated with radiological stages. Analysis of 1230 patients","volume":"69","author":"Perez-Alvarez","year":"2019","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib113","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib89","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-0030-1262207","article-title":"Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET","volume":"31","author":"Costabel","year":"2010","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.rmed.2014.12.012","article-title":"Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan","volume":"109","author":"Sawahata","year":"2015","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib68","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.201503-0418OC","article-title":"Identification of immune-relevant factors conferring sarcoidosis genetic risk","volume":"192","author":"Fischer","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib97","first-page":"519","article-title":"Enigmas in sarcoidosis","volume":"162","author":"Chesnutt","year":"1995","journal-title":"West. J. Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib24","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1038\/s41598-018-27554-3","article-title":"Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan","volume":"8","author":"Hattori","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib204","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jbspin.2019.10.001","article-title":"Sarcoidosis presenting with and without Lofgren's syndrome: clinical, radiological and behavioral differences observed in a group of 691patients","volume":"87","author":"Rubio-Rivas","year":"2020","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00444-2019","article-title":"Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study","volume":"54","author":"Fidler","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib17","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden","volume":"48","author":"Arkema","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib19","first-page":"61","article-title":"The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study","volume":"12","author":"Pietinalho","year":"1995","journal-title":"Sarcoidosis"},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1445-5994.2007.01365.x","article-title":"Sarcoidosis in Australia","volume":"37","author":"Gillman","year":"2007","journal-title":"Intern. Med. J."},{"issue":"12","key":"10.1016\/j.jaut.2023.103107_bib29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.jaut.2023.103107_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016839","article-title":"Risk of sarcoidosis and seropositive rheumatoid arthritis from occupational silica exposure in Swedish iron foundries: a retrospective cohort study","volume":"7","author":"Vihlborg","year":"2017","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib31","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.06-2114","article-title":"World Trade Center \"sarcoid-like\" granulomatous pulmonary disease in New York City Fire Department rescue workers","volume":"131","author":"Izbicki","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/IAI.00732-06","article-title":"Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis","volume":"75","author":"Drake","year":"2007","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12890-016-0332-z","article-title":"Is there any association between Sarcoidosis and infectious agents?: a systematic review and meta-analysis","volume":"16","author":"Esteves","year":"2016","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib35","first-page":"33","article-title":"Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis","volume":"22","author":"Ishige","year":"2005","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"11","key":"10.1016\/j.jaut.2023.103107_bib36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10654-020-00611-w","article-title":"Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case-control study","volume":"35","author":"Rossides","year":"2020","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.jaut.2023.103107_bib37","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3389\/fimmu.2018.01516","article-title":"In situ humoral immunity to vimentin in HLA-drb1*03(+) patients with pulmonary sarcoidosis","volume":"9","author":"Kinloch","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/cei.12138","article-title":"Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis","volume":"173","author":"Gabrilovich","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1164\/ajrccm.152.1.7599865","article-title":"Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis","volume":"152","author":"Girgis","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib40","first-page":"139","article-title":"Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis","volume":"13","author":"Ishioka","year":"1996","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000029536","article-title":"Significance of the interleukin-1 receptor antagonist\/interleukin-1 beta ratio as a prognostic factor in patients with pulmonary sarcoidosis","volume":"67","author":"Mikuniya","year":"2000","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib42","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.166.1.642","article-title":"IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs","volume":"166","author":"Shigehara","year":"2001","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib43","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cei.12403","article-title":"Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Lofgren's syndrome","volume":"178","author":"Ostadkarampour","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib45","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI93537","article-title":"Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction","volume":"127","author":"Weigt","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"45","key":"10.1016\/j.jaut.2023.103107_bib46","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1073\/pnas.1417789111","article-title":"Mathematical model of sarcoidosis","volume":"111","author":"Hao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2023.103107_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-4-10","article-title":"Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis","volume":"4","author":"Palchevskiy","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib48","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1183\/09031936.00157508","article-title":"CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis","volume":"34","author":"Busuttil","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib49","first-page":"8","article-title":"Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis","volume":"37","author":"Miyata","year":"2020","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"7","key":"10.1016\/j.jaut.2023.103107_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038083","article-title":"Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood","volume":"7","author":"Thillai","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12931-020-01537-3","article-title":"Differential transcriptomics in sarcoidosis lung and lymph node granulomas with comparisons to pathogen-specific granulomas","volume":"21","author":"Casanova","year":"2020","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib52","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.jaut.2023.103107_bib53","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","article-title":"Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS)","volume":"164","author":"Rybicki","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1157\/13098420","article-title":"[Epidemiology of sarcoidosis]","volume":"43","author":"Fernandez Fabrellas","year":"2007","journal-title":"Arch. Bronconeumol."},{"issue":"10","key":"10.1016\/j.jaut.2023.103107_bib55","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/thx.2007.094060","article-title":"Heredity in sarcoidosis: a registry-based twin study","volume":"63","author":"Sverrild","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jaut.2023.103107_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1465-9921-11-25","article-title":"Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients","volume":"11","author":"Grunewald","year":"2010","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib57","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1164\/rccm.200412-1707OC","article-title":"C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis","volume":"172","author":"Spagnolo","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib58","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2796.2008.01984.x","article-title":"A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Lofgren's syndrome","volume":"264","author":"Spagnolo","year":"2008","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humimm.2011.10.016","article-title":"HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis","volume":"73","author":"Wennerstrom","year":"2012","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2023.103107_bib60","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.rmed.2012.08.009","article-title":"BTNL2 gene polymorphism associations with susceptibility and phenotype expression in sarcoidosis","volume":"106","author":"Morais","year":"2012","journal-title":"Respir. Med."},{"issue":"9","key":"10.1016\/j.jaut.2023.103107_bib61","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.200209-1097OC","article-title":"Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans","volume":"167","author":"Iannuzzi","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib62","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/378097","article-title":"HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"20","key":"10.1016\/j.jaut.2023.103107_bib63","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/hmg\/ddq325","article-title":"Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups","volume":"19","author":"Sato","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.jaut.2023.103107_bib64","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/ajrccm.165.8.200110-0320","article-title":"Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis","volume":"165","author":"Grutters","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib65","first-page":"131","article-title":"TNF-alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis","volume":"27","author":"Kieszko","year":"2010","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"8","key":"10.1016\/j.jaut.2023.103107_bib66","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/jid.2008.456","article-title":"Variation in the lymphotoxin-alpha\/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis","volume":"129","author":"McDougal","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.jaut.2023.103107_bib67","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1006\/cyto.1997.0224","article-title":"Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis","volume":"9","author":"Seitzer","year":"1997","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib69","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1183\/09031936.00049410","article-title":"Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes","volume":"37","author":"Fischer","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.jaut.2023.103107_bib70","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1164\/rccm.200303-456OC","article-title":"C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome","volume":"168","author":"Spagnolo","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-0039.2011.01808.x","article-title":"Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis","volume":"79","author":"Veltkamp","year":"2012","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib72","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/qjmed\/hcx243","article-title":"Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis","volume":"111","author":"Cooke","year":"2018","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib74","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1165\/ajrcmb.22.6.3745","article-title":"The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis","volume":"22","author":"Maliarik","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"9","key":"10.1016\/j.jaut.2023.103107_bib75","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ng.198","article-title":"Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis","volume":"40","author":"Hofmann","year":"2008","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib76","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5858\/arpa.2014-0051-RA","article-title":"Four decades of necrotizing sarcoid granulomatosis: what do we know now?","volume":"139","author":"Rosen","year":"2015","journal-title":"Arch. Pathol. Lab Med."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib77","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/03009742.2017.1420818","article-title":"Clinical and biochemical presentation of sarcoidosis with high and normal serum angiotensin-converting enzyme","volume":"47","author":"Sejdic","year":"2018","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS Clinical Statement on pulmonary sarcoidosis","volume":"76","author":"Thillai","year":"2021","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193122","article-title":"Role of serum immunoglobulins for predicting sarcoidosis outcome: a cohort study","volume":"13","author":"Belhomme","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jaut.2023.103107_bib80","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1210\/jc.2013-2016","article-title":"Calcitriol-mediated hypercalcemia: causes and course in 101 patients","volume":"98","author":"Donovan","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib81","first-page":"113","article-title":"Calcium and vitamin D metabolism in sarcoidosis","volume":"30","author":"Baughman","year":"2013","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib82","first-page":"167","article-title":"Nephrolithiasis as a presenting feature of chronic sarcoidosis: a prospective study","volume":"13","author":"Rizzato","year":"1996","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib83","first-page":"126","article-title":"Frequency of kidney disease in chronic sarcoidosis","volume":"20","author":"Bergner","year":"2003","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib84","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00025212","article-title":"Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function","volume":"40","author":"Nunes","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103107_bib85","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years' observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br. Med. J."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib87","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1183\/09031936.00166809","article-title":"Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis","volume":"36","author":"Boros","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"23","key":"10.1016\/j.jaut.2023.103107_bib88","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.2013.5823","article-title":"Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial","volume":"309","author":"von Bartheld","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib90","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4187\/respcare.02101","article-title":"Efficacy and safety of conventional transbronchial needle aspiration in sarcoidosis: a systematic review and meta-analysis","volume":"58","author":"Agarwal","year":"2013","journal-title":"Respir. Care"},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib91","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.rmed.2012.02.014","article-title":"Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis","volume":"106","author":"Agarwal","year":"2012","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib93","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0028-1098315","article-title":"Mediastinal lymph node biopsy in sarcoidosis","volume":"11","author":"Mikhail","year":"1979","journal-title":"Endoscopy"},{"issue":"8","key":"10.1016\/j.jaut.2023.103107_bib95","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib96","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2214\/ajr.117.4.777","article-title":"Pulmonary sarcoidosis. Roentgenologic analysis of 150 patients","volume":"117","author":"Kirks","year":"1973","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2049-6958-8-8","article-title":"HRCT findings of pulmonary sarcoidosis; relation to pulmonary function tests","volume":"8","author":"Ors","year":"2013","journal-title":"Multidiscip. Respir. Med."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib106","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2214\/ajr.159.3.1503008","article-title":"Pulmonary sarcoidosis: changes on follow-up CT examination","volume":"159","author":"Murdoch","year":"1992","journal-title":"AJR Am. J. Roentgenol."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib107","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0009-9260(96)80343-6","article-title":"The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis: a CT study","volume":"51","author":"Gawne-Cain","year":"1996","journal-title":"Clin. Radiol."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib108","first-page":"123","article-title":"18F-FDG PET as a predictor of pulmonary function in sarcoidosis","volume":"28","author":"Keijsers","year":"2011","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib109","first-page":"372","article-title":"Role of serial F-18 FDG PET\/CT scans in assessing treatment response and predicting relapses in patients with symptomatic sarcoidosis","volume":"33","author":"Maturu","year":"2016","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib110","first-page":"231","article-title":"Mortality in sarcoidosis. A changing pattern of the causes of death","volume":"62","author":"Huang","year":"1981","journal-title":"Eur. J. Respir. Dis."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib111","first-page":"154","article-title":"Predicting respiratory failure in sarcoidosis patients","volume":"14","author":"Baughman","year":"1997","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib112","first-page":"204","article-title":"Two year prognosis of sarcoidosis: the ACCESS experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"11","key":"10.1016\/j.jaut.2023.103107_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143371","article-title":"Cumulative incidence and predictors of progression in corticosteroid-naive patients with sarcoidosis","volume":"10","author":"Inoue","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib115","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.04.00070503","article-title":"Sarcoidosis: social predictors of severity at presentation","volume":"24","author":"Rabin","year":"2004","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib99","first-page":"483","article-title":"Sarcoidosis: clinical features and management","volume":"51","author":"Siltzbach","year":"1967","journal-title":"Med. Clin."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib101","first-page":"27","article-title":"Presentation of sarcoidosis and outcome of pulmonary changes","volume":"29","author":"Romer","year":"1982","journal-title":"Dan. Med. Bull."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib102","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib103","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib104","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib116","first-page":"158","article-title":"The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases","volume":"17","author":"Pietinalho","year":"2000","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib117","first-page":"167","article-title":"Sarcoidosis: a long-term follow up study","volume":"17","author":"Chappell","year":"2000","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib118","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000196341","article-title":"Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases","volume":"61","author":"Mana","year":"1994","journal-title":"Respiration"},{"key":"10.1016\/j.jaut.2023.103107_bib119","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.jaut.2023.103107_bib120","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1513\/AnnalsATS.202102-212CME","article-title":"Clinical presentation and treatment of high-risk sarcoidosis","volume":"18","author":"Perlman","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib121","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9343(85)90463-2","article-title":"Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 years","volume":"78","author":"Reich","year":"1985","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2023.103107_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105997","article-title":"Predictors of mortality in fibrosing pulmonary sarcoidosis","volume":"169","author":"Jeny","year":"2020","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib124","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00330-004-2480-4","article-title":"CT findings in severe thoracic sarcoidosis","volume":"15","author":"Hennebicque","year":"2005","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib125","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1038\/s41598-019-40030-w","article-title":"Clinical features and outcomes of patients with sarcoidosis-associated pulmonary hypertension","volume":"9","author":"Parikh","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib126","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis","volume":"61","author":"Nunes","year":"2006","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib127","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01747-2019","article-title":"Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry","volume":"55","author":"Shlobin","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib128","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.chest.2021.07.2162","article-title":"Riociguat for sarcoidosis-associated pulmonary hypertension: results of a 1-year double-blind, placebo-controlled trial","volume":"161","author":"Baughman","year":"2022","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib131","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1378\/chest.13-1766","article-title":"Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial","volume":"145","author":"Baughman","year":"2014","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib132","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/00004728-198611000-00006","article-title":"Typical and atypical CT manifestations of pulmonary sarcoidosis","volume":"10","author":"Hamper","year":"1986","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib133","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1148\/108.3.585","article-title":"Sarcoidosis, hilar adenopathy, and pulmonary artery narrowing","volume":"108","author":"Westcott","year":"1973","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib134","first-page":"809","article-title":"Sarcoidosis simulating pulmonary veno-occlusive disease","volume":"134","author":"Hoffstein","year":"1986","journal-title":"Am. Rev. Respir. Dis."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib135","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.chest.2017.03.022","article-title":"Sarcoidosis and risk of VTE: validation with big data","volume":"151","author":"Yaqoob","year":"2017","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib136","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chest.2016.09.009","article-title":"Association of sarcoidosis with increased risk of VTE: a population-based study, 1976 to 2013","volume":"151","author":"Ungprasert","year":"2017","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib137","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1378\/chest.127.2.472","article-title":"Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and evolution","volume":"127","author":"Chambellan","year":"2005","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib138","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1378\/chest.106.3.677","article-title":"Dilatation of bronchial stenoses due to sarcoidosis using a flexible fiberoptic bronchoscope","volume":"106","author":"Fouty","year":"1994","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib139","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02396-2016","article-title":"Chronic pulmonary aspergillosis complicating sarcoidosis","volume":"49","author":"Uzunhan","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1378\/chest.86.4.585","article-title":"Aspergillomas complicating sarcoidosis. A prospective study in 100 patients","volume":"86","author":"Wollschlager","year":"1984","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041178","article-title":"Severe fatigue is highly prevalent in patients with IPF or sarcoidosis","volume":"9","author":"Bloem","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib142","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1378\/chest.10-2629","article-title":"Characterization of chronic fatigue in patients with sarcoidosis in clinical remission","volume":"140","author":"Korenromp","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib143","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000314225","article-title":"Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment","volume":"80","author":"Elfferich","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.jaut.2023.103107_bib144","first-page":"CD006704","article-title":"Drug therapy for the management of cancer-related fatigue","volume":"7","author":"Minton","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jaut.2023.103107_bib145","series-title":"When to treat sarcoidosis","first-page":"316","author":"Culver","year":"2022"},{"key":"10.1016\/j.jaut.2023.103107_bib146","first-page":"CD001114","article-title":"Corticosteroids for pulmonary sarcoidosis","volume":"2","author":"Paramothayan","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.jaut.2023.103107_bib147","doi-asserted-by":"crossref","DOI":"10.1001\/jama.287.10.1301","article-title":"Corticosteroid therapy in pulmonary sarcoidosis: a systematic review","volume":"287","author":"Paramothayan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2023.103107_bib148","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.rmed.2017.10.022","article-title":"No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis","volume":"138","author":"Broos","year":"2018","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib149","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/thx.51.3.238","article-title":"British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment","volume":"51","author":"Gibson","year":"1996","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.121.1.24","article-title":"Early treatment of stage II sarcoidosis improves 5-year pulmonary function","volume":"121","author":"Pietinalho","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib151","first-page":"215","article-title":"Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease","volume":"60","author":"Selroos","year":"1979","journal-title":"Scand. J. Respir. Dis."},{"issue":"155","key":"10.1016\/j.jaut.2023.103107_bib152","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0146-2019","article-title":"Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis","volume":"29","author":"Rahaghi","year":"2020","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MAJ.0b013e3181b97635","article-title":"Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations","volume":"339","author":"McKinzie","year":"2010","journal-title":"Am. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.jaut.2023.103107_bib154","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib155","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2023.103107_bib156","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib157","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1183\/23120541.00028-2021","article-title":"Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids","volume":"7","author":"Entrop","year":"2021","journal-title":"ERJ Open Res."},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib158","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCP.0b013e3283642a7a","article-title":"Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide","volume":"19","author":"Cremers","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib159","first-page":"217","article-title":"Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: a single center real-world study","volume":"36","author":"Fang","year":"2019","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib160","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoicdosis, Vasc. Diffuse Lung Dis.: Off. J. WASOG"},{"issue":"7","key":"10.1016\/j.jaut.2023.103107_bib161","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/diagnostics11071289","article-title":"Efficacy and tolerability of methotrexate and methylprednisolone in a comparative assessment of the primary and long-term outcomes in patients with pulmonary sarcoidosis","volume":"11","author":"Gavrysyuk","year":"2021","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib162","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12890-020-01290-9","article-title":"Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study","volume":"20","author":"Kahlmann","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib163","first-page":"87","article-title":"Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis","volume":"16","author":"Lewis","year":"1999","journal-title":"Sarcoicdosis, Vasc. Diffuse Lung Dis.: Off. J. WASOG"},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib164","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1183\/09031936.99.14511179","article-title":"Treatment of chronic sarcoidosis with an azathioprine\/prednisolone regimen","volume":"14","author":"Muller-Quernheim","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib165","first-page":"107","article-title":"Azathioprine treatment of chronic pulmonary sarcoidosis","volume":"2","author":"Pacheco","year":"1985","journal-title":"Sarcoidosis"},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib166","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.jaut.2023.103107_bib167","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib168","article-title":"Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period","volume":"37","author":"Baughman","year":"2020","journal-title":"Sarcoicdosis, Vasc. Diffuse Lung Dis.: Off. J. WASOG"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib169","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1440-1843.2009.01518.x","article-title":"Clinical outcomes in sarcoidosis after cessation of infliximab treatment","volume":"14","author":"Panselinas","year":"2009","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib170","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1183\/09031936.00055213","article-title":"Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis","volume":"43","author":"Vorselaars","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib171","first-page":"46","article-title":"Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis","volume":"31","author":"Sweiss","year":"2014","journal-title":"Sarcoicdosis, Vasc. Diffuse Lung Dis.: Off. J. WASOG"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib172","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1752-699X.2011.00276.x","article-title":"Effect of the TNF-\u03b1 inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET","volume":"6","author":"Milman","year":"2012","journal-title":"Clin. Res. J"},{"key":"10.1016\/j.jaut.2023.103107_bib173","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.rmed.2016.04.011","article-title":"Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab","volume":"115","author":"Crommelin","year":"2016","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib174","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11845-015-1363-9","article-title":"Adalimumab for refractory pulmonary sarcoidosis","volume":"185","author":"Minnis","year":"2016","journal-title":"Ir. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","article-title":"Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis","volume":"124","author":"Utz","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib176","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib177","first-page":"43","article-title":"Leflunomide for chronic sarcoidosis","volume":"21","author":"Baughman","year":"2004","journal-title":"Sarcoicdosis, Vasc. Diffuse Lung Dis.: Off. J. WASOG"},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib178","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1183\/09031936.00195010","article-title":"Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis","volume":"38","author":"Sahoo","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib179","first-page":"376","article-title":"Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study","volume":"86","author":"Brill","year":"2013","journal-title":"Respiration; Int. Rev. Thoracic Dis."},{"issue":"11","key":"10.1016\/j.jaut.2023.103107_bib180","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.rmed.2014.09.013","article-title":"Efficacy of mycophenolate mofetil in sarcoidosis","volume":"108","author":"Hamzeh","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2023.103107_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2019.101840","article-title":"Mycophenolate mofetil as an alternative treatment in sarcoidosis","volume":"58","author":"Papiris","year":"2019","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib182","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1183\/09031936.00224513","article-title":"Rituximab in the treatment of refractory pulmonary sarcoidosis","volume":"43","author":"Sweiss","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103107_bib183","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rmed.2015.11.007","article-title":"A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients","volume":"110","author":"Baughman","year":"2016","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib184","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00408-017-9994-4","article-title":"Repository corticotropin for chronic pulmonary sarcoidosis","volume":"195","author":"Baughman","year":"2017","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib185","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1164\/ajrccm.155.5.9154873","article-title":"Pentoxifylline in treatment of sarcoidosis","volume":"155","author":"Zabel","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib186","first-page":"121","article-title":"Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis","volume":"26","author":"Park","year":"2009","journal-title":"Sarcoicdosis, Vasc. Diffuse Lung Dis.: Off. J. WASOG"},{"key":"10.1016\/j.jaut.2023.103107_bib187","article-title":"Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents","volume":"1","author":"Sharp","year":"2019","journal-title":"Respir. Med. X"},{"key":"10.1016\/j.jaut.2023.103107_bib188","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ebiom.2019.10.050","article-title":"Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease","volume":"50","author":"Hoffmann-Vold","year":"2019","journal-title":"EBioMedicine"},{"issue":"18","key":"10.1016\/j.jaut.2023.103107_bib189","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib190","first-page":"87","article-title":"Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy","volume":"37","author":"Syed","year":"2020","journal-title":"Sarcoicdosis, Vasc. Diffuse Lung Dis.: Off. J. WASOG"},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib191","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/HCR.0000000000000307","article-title":"Efficacy of a structured exercise program for improving functional capacity and quality of life in patients with stage 3 and 4 sarcoidosis: a randomized controlled trial","volume":"38","author":"Naz","year":"2018","journal-title":"J. Cardiopulm Rehabil. Prev."},{"issue":"5","key":"10.1016\/j.jaut.2023.103107_bib192","first-page":"423","article-title":"The short- and long-term impact of pulmonary rehabilitation in subjects with sarcoidosis: a prospective study and review of the literature","volume":"100","author":"Guber","year":"2021","journal-title":"Respiration; Int. Rev. Thoracic Dis."},{"key":"10.1016\/j.jaut.2023.103107_bib193","first-page":"1","article-title":"Long-term effects of pulmonary rehabilitation on daily life physical activity of patients with stage IV sarcoidosis: a randomized controlled trial","volume":"77","author":"Wallaert","year":"2020","journal-title":"Respir Med Res"},{"issue":"10","key":"10.1016\/j.jaut.2023.103107_bib194","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1164\/rccm.202009-3608ST","article-title":"Home oxygen therapy for adults with chronic lung disease. An official American thoracic society clinical practice guideline","volume":"202","author":"Jacobs","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib195","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1378\/chest.125.3.990","article-title":"Sarcoidosis, race, and short-term outcomes following lung transplantation","volume":"125","author":"Shorr","year":"2004","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jaut.2023.103107_bib196","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/j.healun.2020.01.686","volume":"39","author":"Pavec","year":"2020","journal-title":"J. Heart Lung Transplant."},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib197","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03358-2020","article-title":"Lung transplantation for sarcoidosis: outcome and prognostic factors","volume":"58","author":"Le Pavec","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jaut.2023.103107_bib198","first-page":"52","article-title":"The late follow-up of chronic sarcoid patients previously treated with corticosteroids","volume":"15","author":"Rizzato","year":"1998","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"3","key":"10.1016\/j.jaut.2023.103107_bib199","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.111.3.623","article-title":"Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy","volume":"111","author":"Gottlieb","year":"1997","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2023.103107_bib200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-199903000-00001","article-title":"The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital","volume":"78","author":"Johns","year":"1999","journal-title":"Medicine (Baltim.)"},{"issue":"4 Pt 1","key":"10.1016\/j.jaut.2023.103107_bib201","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/ajrccm.149.4.8143052","article-title":"Outcome of the treatment for sarcoidosis","volume":"149","author":"Hunninghake","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T06:39:46Z","timestamp":1738478386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841123001166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":203,"alternative-id":["S0896841123001166"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103107","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary sarcoidosis: A comprehensive review: Past to present","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103107"}}